Top

BMC Neurology

Published in:

Open Access 01-12-2016 | Technical advance

Ultrasound-guided botulinum toxin A injection in the treatment of belly dancer’s dyskinesia

Authors: Asmahan Alshubaili, Hussam Abou-Al-Shaar, Ponnusamy Santhamoorthy, Hosam Attia, Saeed Bohlega

Published in: BMC Neurology | Issue 1/2016

Abstract

Background

Belly dancer’s dyskinesia is an extremely rare condition. It manifests as semicontinuous, slow, writhing, sinuous abdominal wall movements that are bothersome to the patient. Management of this condition is extremely difficult and challenging.

Methods

We describe four patients with belly dancer’s dyskinesia who were treated with Botulinum Toxin A (BTX) injections under ultrasound guidance.

Results

All patients underwent the same BTX injection procedure using an aseptic technique under ultrasound guidance. The patients responded well to the BTX injections after an unsatisfactory course of medical treatment. The patients reported complete abolishment of abnormal abdominal movements with no side effects.

Conclusions

We report a cohort of patients with belly dancer dyskinesia treated successfully with BTX injections. Ultrasound guidance for injections increases the accuracy and reduces the risk of the complications. BTX injection under ultrasound guidance is a safe and effective treatment modality that should be employed as a first-line in the management of patients with belly dancer’s dyskinesia.

Iliceto G, Thompson PD, Day BL, Rothwell JC, Lees AJ, Marsden CD. Diaphragmatic flutter, the moving umbilicus syndrome, and “belly dancer’s” dyskinesia. Mov Disord. 1990;5(1):15–22.CrossRefPubMed

Shan DE, Kwan SY, Ho HH, Su MS. Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy. Mov Disord. 1996;11(4):455–7.CrossRefPubMed

Caviness JN, Gabellini A, Kneebone CS, Thompson PD, Lees AJ, Marsden CD. Unusual focal dyskinesias: the ears, the shoulders, the back, and the abdomen. Mov Disord. 1994;9(5):531–8.CrossRefPubMed

Schrader C, Capelle H, Kinfe T, Krauss JK. Pallidal deep brain stimulation in “belly dancer’s dyskinesia.”. Mov Disord. 2009;24(11):1698–700.CrossRefPubMed

Tamburin S, Idone D, Zanette G. Belly dancer’s myoclonus and chronic abdominal pain: pain-related dysinhibition of a spinal cord central pattern generator? Parkinsonism Relat Disord. 2007;13(5):317–20.CrossRefPubMed

Amin OS, Abdulkarim QH, Shaikhani M. Intermittent bursts of abdominal wall jerky movements: belly dancer’s syndrome?. BMJ Case Rep. 2012;2012. doi:10.1136/bcr-2012-007393.

Lim EC, Seet RC. Botulinum toxin injections to treat belly dancer’s dyskinesia. Mov Disord. 2009;24(9):1401.CrossRefPubMed

Carecchio M, Collini A, Comi C, Cantello R, Bhatia KP, Monaco F. Levodopa-induced belly dancer’s dyskinesias in Parkinson’s disease: report of one case. Mov Disord. 2010;25(11):1760–2.CrossRefPubMed

Linazasoro G, Van Blercom N, Lasa A, Fernández JM, Aranzábal I. Etiological and therapeutical observations in a case of belly dancer’s dyskinesia. Mov Disord. 2005;20(2):251–3.CrossRefPubMed

10.

Roggendorf J, Burghaus L, Liu WC, Weisenbach S, Eggers C, Fink GR, et al. Belly dancer’s syndrome following central pontine and extrapontine myelinolysis. Mov Disord. 2007;22(6):892–4.CrossRefPubMed

11.

Inghilleri M, Conte A, Frasca V, Vaudano AE, Meco G. Belly dance syndrome due to spinal myoclonus. Mov Disord. 2006;21(3):394–6.CrossRefPubMed

12.

Kono I, Ueda Y, Araki K, Nakajima K, Shibasaki H. Spinal myoclonus resembling belly dance. Mov Disord. 1994;9(3):325–9.CrossRefPubMed

13.

Shamim EA, Hallett M. Intramedullary spinal tumor causing “belly dancer syndrome”. Mov Disord. 2007;22(11):1673–4.CrossRefPubMed

14.

Lobsien E, Gruber D, Schneider GH, Kühn AA, Kupsch A. Iatrogenic belly dancer syndrome following quadruple deep brain stimulation in a patient with myoclonus dystonia (DYT11). Mov Disord. 2010;25(15):2692–3.CrossRefPubMed

15.

Coelho M, Kyllerman M. Belly dancer syndrome. Acta Paediatr. 2012;101(9):e386–387.CrossRefPubMed

16.

Lim EC, Seet RC. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurol Scand. 2008;117(2):73–84.PubMed

17.

Nathan PW. Painful legs and moving toes: evidence on the site of the lesion. J Neurol Neurosurg Psychiatry. 1978;41(10):934–9.CrossRefPubMedPubMedCentral

18.

Schott GD. The relationship of peripheral trauma and pain to dystonia. J Neurol Neurosurg Psychiatry. 1985;48(7):698–701.CrossRefPubMedPubMedCentral

19.

Li B, Peet NP, Butler MM, Burnett JC, Moir DT, Bowlin TL. Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication. Molecules. 2010;16(1):202–20.CrossRefPubMed

20.

Bihari K. Safety, effectiveness, and duration of effect of BOTOX after switching from dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Curr Med Res Opin. 2005;21(3):433–8.CrossRefPubMed

Title: Ultrasound-guided botulinum toxin A injection in the treatment of belly dancer’s dyskinesia
Authors: Asmahan Alshubaili
Hussam Abou-Al-Shaar
Ponnusamy Santhamoorthy
Hosam Attia
Saeed Bohlega
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-016-0746-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ultrasound-guided botulinum toxin A injection in the treatment of belly dancer’s dyskinesia

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)

Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis

Assessment of primary rehabilitation needs in neurological rehabilitation: translation, adaptation and face validity of the Danish version of Rehabilitation Complexity Scale-Extended

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40

The relevance of cortical lesions in patients with multiple sclerosis

Comparison of repair of peripheral nerve transection in predegenerated muscle with and without a vein graft